Close Menu

NEW YORK ─ Antibiotic susceptibility test developer Gradientech said on Wednesday that it has closed an oversubscribed financing round totaling $9 million.

The financing round was oversubscribed by almost 200 percent and will support Gradientech in finalizing the development of its QuickMIC diagnostic system and initiating a market introduction, Sara Thorslund, the firm's CEO and cofounder, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.